← Back to Vital Edge Science
← Back to Vital Edge Science Compound Comparison Tool

How are these compounds
scientifically different?

Compare mechanisms, targets, research profiles and pharmacokinetics for up to 4 compounds side by side. This maps what is scientifically known — it does not tell you which compound to choose.

This is a scientific comparison, not a recommendation. It does not answer "which should I take?" — for potential combination-specific considerations, see the Interaction Checker; for regulatory/clinical-development history, see the Research Status Explorer.

KPV × Melanotan II × 2 of 4 selected View comparison

KPV

α-MSH-derived tripeptide

Remove
VS

Melanotan II

Cyclic melanocortin agonist

Remove

Target & Mechanism Comparison

Primary molecular targets for each selected compound, drawn directly from each compound's structured scientific record. Not every compound has a single conventional receptor target — where that's the case, its differentiating mechanism is noted below instead.

← Scroll to see all compounds →

Target KPVMelanotan II
✓ —
— ✓

What These Compounds Share

No direct target, secondary target, pathway tag, or research area is shared by all selected compounds — see Key Differences below. This reflects the structured data as recorded, not an absence of any conceivable relationship.

Key Differences

KPV IL-1-associated is a direct target of KPV that none of the other selected compounds share. A three-amino-acid α-MSH fragment researched predominantly for inflammatory rather than pigmentation biology.
Melanotan II MELANOCORTIN is a direct target of Melanotan II that none of the other selected compounds share. Broader melanocortin receptor activity than Melanotan I.

Compound Detail

KPV
What is it?
A tiny fragment of a natural hormone, studied for calming inflammation.
What are people researching/using it for?
Studied mainly for gut and skin inflammation.
Other uses being trialed
General inflammatory-condition research
Worth knowing
Human administration research is very limited / insufficient.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
A three-amino-acid α-MSH fragment researched predominantly for inflammatory signalling rather than pigmentation biology.
Tripeptide · 3 amino acids · Lys-Pro-Val · Derived fragment of α-MSH
Primary Targets & Biological System
Inflammatory signalling

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
The C-terminal tripeptide fragment of α-MSH, but its anti-inflammatory research findings are not simply attributed to melanocortin receptor activity the way the full α-MSH molecule's are -- some experimental work suggests KPV's effects on inflammatory signalling may occur independently of melanocortin receptors altogether. Research has implicated interference with IL-1β-associated signalling (a key inflammatory cytokine pathway) and NF-κB-related processes (a central switch for inflammatory gene expression), studied particularly in gut and skin inflammation models.
Research Areas
Inflammatory signallingIntestinal inflammatory modelsSkin inflammationImmune-cell migrationIL-1-associated biology
Research Profile
Human administration: None identified Preclinical: Available
Pharmacokinetics
Not adequately established
Research Routes
Not established in humans (descriptive only — not administration or dosing guidance)
Key Differentiator
A three-amino-acid α-MSH fragment researched predominantly for inflammatory rather than pigmentation biology.
Considerations
Research Limitations
Human administration research is very limited / insufficient.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

Psoriasis / eczema
Preclinical skin-inflammation research has investigated topical KPV for inflammatory skin conditions, extending from its gut-inflammation research base. No established human dermatology evidence.
Availability & Sources
Current Vital Edge Testing
Batch 2 · tested Oct 2026 · 99.036% purity, 11.08mg content Purity/ID report
Available As (Vital Edge Science)
KPV · A$49.95 A$64.95
Browse products →
View Research Sources (1) →
Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides
Preclinical (animal) · PMID 12750433

Supports treating KPV's anti-inflammatory effects as potentially receptor-independent rather than a conventional melanocortin agonist action.

Supports: mechanism_summary, key_differentiator

Melanotan II
What is it?
A lab-made peptide that broadly activates the body's pigmentation and appetite-signalling system.
What are people researching/using it for?
Studied for skin tanning/pigmentation.
Other uses being trialed
Sexual-response researchAppetite-related research
Worth knowing
Not MC1R-selective -- broader melanocortin receptor activity than Melanotan I. Early human trials were small (3-20 participants) and used the compound directly, not the more targeted derivative developed afterward (bremelanotide/PT-141).

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
A cyclic α-MSH analogue with broader melanocortin receptor activity than Melanotan I.
Synthetic cyclic α-MSH analogue · Synthetic analogue
Also known as: MT-II
Primary Targets & Biological System
Melanocortin signalling

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
A cyclic analogue of α-MSH that activates multiple melanocortin receptors rather than being selective for any single one -- unlike Melanotan I, which is predominantly MC1R-focused. This broader receptor activity is the mechanistic reason Melanotan II's research interest extends beyond pigmentation (MC1R's primary domain) into appetite and sexual-response research, since other melanocortin receptors in the family (such as MC4R) are more strongly linked to those functions.
Research Areas
PigmentationMelanocortin signallingSexual-response researchAppetite/CNS melanocortin biology
Research Profile
Human administration: Limited Preclinical: Available
Pharmacokinetics
Not displayed as a definitive value without a direct source.
Research Routes
Subcutaneous (early human research) (descriptive only — not administration or dosing guidance)
Key Differentiator
Broader melanocortin receptor activity than Melanotan I.
Considerations
Research Limitations
Not MC1R-selective -- broader melanocortin receptor activity than Melanotan I. Early human trials were small (3-20 participants) and used the compound directly, not the more targeted derivative developed afterward (bremelanotide/PT-141).
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

Sexual response / erectile function
Two double-blind, placebo-controlled human crossover trials directly tested Melanotan II for this use: in one, 8 of 10 men with psychogenic erectile dysfunction developed clinically apparent erections; in a larger follow-up of 20 men with psychogenic or organic ED, 17 of 20 responded, and increased sexual desire was reported after 68% of Melanotan II doses versus 19% of placebo doses. This is genuine controlled human evidence directly for Melanotan II itself -- it was also the original research basis that led to the development of PT-141/bremelanotide as a more targeted follow-on compound, but Melanotan II has its own directly-studied human trial history, not merely a precursor role.
Availability & Sources
Current Vital Edge Testing
Available As (Vital Edge Science)
Melanotan II · A$54.95 A$69.95
Browse products →
View Research Sources (3) →
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
Journal of Urology, 1998 · Human Human · 10 men with erectile dysfunction of no known organic cause · Not specified in this record -- see prescribing/trial documentation · PMID 9679884

Double-blind, placebo-controlled crossover, RigiScan-monitored over 6 hours. Clinically apparent erections in 8/10 men on Melanotan II. Mean tip-rigidity >80% duration: 38.0 min (MT-II) vs 3.0 min (placebo), P=0.0045.

Supports: experimental_research

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II
International Journal of Impotence Research, 2000 · Human Human · 20 men with psychogenic or organic erectile dysfunction · PMID 11035391

Double-blind, placebo-controlled crossover, RigiScan-monitored. Erection without sexual stimulation in 17/20 men (mean 41 min tip rigidity >80%). Increased sexual desire reported after 68% of MT-II doses vs 19% of placebo doses (P<0.01). Severe nausea in 12.9% at 0.025 mg/kg.

Supports: experimental_research

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
Life Sciences, 1996 · Human Human · 3 normal male volunteers · Not specified in this record · PMID 8637402

Single-blind, alternating-day, placebo-controlled Phase I safety/pigmentation study. Mild nausea and stretching/yawning correlating with spontaneous erections; increased pigmentation of face/upper body/buttock in 2 of 3 subjects. Recommended future Phase I dose: 0.025 mg/kg/day.

Supports: mechanism_summary, short_description

Common Research Comparisons

Frequently studied groupings — not recommendations.

Browse more compounds

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Choose a compound

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Simplified for general understanding — see this compound's "How does it work?" section for the full research-level description.